Original language | English |
---|---|
Pages (from-to) | PD2-2-PD2-2 |
Journal | Cancer Research |
Volume | 75 |
Issue number | 9 Supplement |
DOIs | |
Publication status | Published - 1 May 2015 |
Abstract PD2-2: Final efficacy results of the randomized phase III BEATRICE trial evaluating adjuvant bevacizumab-containing therapy in triple-negative early breast cancer
Richard Bell, Julia Brown, Mahesh Parmar, Mark Toi, Thomas Suter, Guenther Steger, Xavier Pivot, John Mackey, Christian Jackisch, Rebecca Dent, Peter Hall, Almut Mecke, Leilani Morales, Louise Provencher, Elzbieta Staroslawska, Roberto Hegg, Laurence Vanlemmens, Andreas Kirsch, Andreas Schneeweiss, Norikazu Masuda
Research output: Contribution to journal › Meeting abstract › peer-review